Trump Trade: Treasury’s Bessent to begin Fed Chair interview this week

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly:

FED CHAIR: Treasury Secretary Bessent plans to begin a round of interviews for candidates that would replace Fed Chair Powell as soon as this Friday, The Wall Street Journal’s Brian Schwartz writes, citing people familiar with the matter. The 11 candidates for the post include Fed governors Christopher Waller and Michelle Bowman, National Economic Council Director Kevin Hassett and former Fed governor Kevin Warsh, the report states.

TARIFFS: Europe’s chemical companies are facing turmoil as U.S. import tariffs disrupt global trade, prompting customers to delay orders, Reuters’ Patricia Weiss, Christoph Steitz and Oliver Denzer report. Publicly traded companies in the space include BASF (BASFY), LyondellBasell (LYB), Linde (LIN), Air Liquide (AIQUY), and AkzoNobel (AKZOY).

TO HOST POLISH PRESIDENT: President Donald Trump is scheduled on Wednesday to host the Polish president in the Oval Office, as leaders in Warsaw and other European countries discuss ongoing security threats posed by Russia’s invasion of Ukraine, ABC News’ Hannah Demissie and Kevin Shalvey report.

COVID VACCINE DATA: Pfizer (PFE) reaffirmed its commitment to transparently and consistently disclosing its research findings regarding its COVID-19 vaccine and to maintaining the integrity of those ongoing studies for all those it serves. Albert Bourla, Chairman and CEO, said in a statement, “The success of Operation Warp Speed and U.S. development of mRNA vaccines is a profound public health achievement. Under President Trump’s leadership, American innovation led the world, helping prevent economic collapse and saving more than 14 million lives globally. Operation Warp Speed restored consumer confidence, saved over $1 trillion in health care costs due to reductions in serious illness and avoidance of hospitalizations, and rapidly scaled up domestic production. This American leadership also delivered a new platform that may drive significant innovation in cancer research. Such an accomplishment would typically be worthy of the Nobel Peace Prize, given its significant impact. President Trump’s call for transparency is welcomed, and we remain deeply committed to that principle. Transparency has always been a cornerstone of trust, and we are dedicated to continuing to provide clear, factual data to the public. To date, data on Pfizer’s COVID-19 vaccine have appeared in over 600 peer-reviewed publications. In addition to the U.S. FDA, detailed data has been submitted to regulators in 130 countries, and, after thorough review and analysis, all approved the vaccine. Many nations, including the United Kingdom, Denmark, Israel, and Turkey, have gone on to generate real-world evidence through their vaccination programs, further validating the vaccine’s safety and effectiveness in everyday settings.”

In response to President Trump’s request, the company provided a link to Pfizer’s website containing numerous published studies and updates on safety, immunogenicity, and efficacy data in “an open and accessible manner,” adding that it will post additional information and studies by the end of the month.